How should I monitor liver function tests in patients who are receiving naltrexone or extended-release naltrexone for their treatment of opioid and or alcohol use disorders? What should I do if a patient receiving naltrexone does develop evidence of a severe elevation of liver function tests or acute hepatitis?
